CoChat

Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy

Barboni, Mirella Telles Salgueiro, Liber, André Maurício Passos, Joachimsthaler, Anneka, Saoudi, Amel, Goyenvalle, Aurélie, Rendon, Alvaro, Roger, Jérome E., Ventura, Dora Fix, Kremers, Jan, Vaillend, Cyrille · 2021 · Neurobiology of Disease
Cited by 11

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2021.105288

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 58

  1. Adiconis, 2018, Comprehensive comparative analysis of 5′-end RNA-sequencing methods, Nat. Methods, 15, 505, 10.1038/s41592-018-0014-2 · DOI
  2. Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem. Biophys. Res. Commun., 238, 492, 10.1006/bbrc.1997.7328 · DOI · Paper page
  3. Aranmolate, 2017, Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy, BMC Neurosci., 18, 63, 10.1186/s12868-017-0381-0 · DOI
  4. Barboni, 2013, ON and OFF electroretinography and contrast sensitivity in Duchenne muscular dystrophy, Invest. Ophthalmol. Vis. Sci., 54, 3195, 10.1167/iovs.13-11700 · DOI
  5. Barboni, 2016, Dystrophin is required for proper functioning of luminance and red-Green cone opponent mechanisms in the human retina, Invest. Ophthalmol. Vis. Sci., 57, 3581, 10.1167/iovs.16-19287 · doi:10.1167/iovs.16-19287
  6. Barboni, 2020, Rescue of Defective Electroretinographic Responses in Dp71-null mice with AAV-mediated Reexpression of Dp71, Invest. Ophthalmol. Vis. Sci., 61, 11, 10.1167/iovs.61.2.11 · DOI · Paper page
  7. Bladen, 2015, The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations, Hum. Mutat., 36, 395, 10.1002/humu.22758 · DOI · Paper page
  8. Blank, 1999, Dystrophin and beta-dystroglycan in photoreceptor terminals from normal and mdx3Cv mouse retinae, Eur. J. Neurosci., 11, 2121, 10.1046/j.1460-9568.1999.00636.x · DOI
  9. Bucher, 2019, The long dystrophin gene product Dp427 modulates retinal function and vascular morphology in response to age and retinal ischemia, Neurochem. Int., 104489
  10. Catalani, 2020, Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy, Cell. Mol. Life Sci.
  11. Choi, 2020, Single-cell RNA sequencing and its combination with protein and DNA analyses, Cells, 9, 10.3390/cells9051130 · DOI
  12. Claudepierre, 1999, Differential distribution of dystrophins in rat retina, Invest. Ophthalmol. Vis. Sci., 40, 1520
  13. Collin, 2020, Mouse models of inherited retinal degeneration with photoreceptor cell loss, Cells, 9
  14. Costa, 2011, Psychophysical measurements of luminance and chromatic spatial and temporal contrast sensitivity in Duchenne muscular dystrophy, Psychology & Neurosci., 4, 67, 10.3922/j.psns.2011.1.008 · doi:10.3922/j.psns.2011.1.008
  15. Cox, 1993, New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin, Nat. Genet., 4, 87, 10.1038/ng0593-87 · DOI · Paper page
  16. Daoud, 2008, Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions, PLoS One, 4
  17. De Becker, 1994, Correlation between electroretinogram findings and molecular analysis in the Duchenne muscular dystrophy phenotype, Br. J. Ophthalmol., 78, 719, 10.1136/bjo.78.9.719 · doi:10.1136/bjo.78.9.719
  18. Desguerre, 2009, Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up, PLoS One, 4, 10.1371/journal.pone.0004347 · DOI · Paper page
  19. D’Souza, 1995, A novel dystrophin isoform is required for normal retinal electrophysiology, Hum. Mol. Genet., 4, 837, 10.1093/hmg/4.5.837 · DOI · Paper page
  20. Girlanda, 1997, Extra-muscle involvement in dystrophinopathies: an electroretinography and evoked potential study, J. Neurol. Sci., 146, 127, 10.1016/S0022-510X(96)00292-4 · doi:10.1016/s0022-510x(96)00292-4
  21. Harazny, 2009, Electrophysiological deficits in the retina of the DBA/2J mouse, Doc. Ophthalmol., 119, 181, 10.1007/s10633-009-9194-5 · DOI
  22. Hauser, 1996, Progress towards gene therapy for Duchenne muscular dystrophy, J. Endocrinol., 149, 373, 10.1677/joe.0.1490373 · doi:10.1677/joe.0.1490373
  23. Hestand, 2010, Tissue-specific transcript annotation and expression profiling with complementary next-generation sequencing technologies, Nucleic Acids Res., 38, 10.1093/nar/gkq602 · DOI
  24. Hoffman, 1987, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, 51, 919, 10.1016/0092-8674(87)90579-4 · DOI · Paper page
  25. Im, 1996, Differential expression of dystrophin isoforms in strains of mdx mice with different mutations, Hum. Mol. Genet., 5, 1149, 10.1093/hmg/5.8.1149 · DOI · Paper page
  26. Ino-ue, 1997, Genotype and electroretinal heterogeneity in Duchenne muscular dystrophy, Exp. Eye Res., 65, 861, 10.1006/exer.1997.0389 · DOI
  27. Jensen, 1995, Duchenne muscular dystrophy: negative electroretinograms and normal dark adaptation. Reappraisal of assignment of X linked incomplete congenital stationary night blindness, J. Med. Genet., 32, 348, 10.1136/jmg.32.5.348 · DOI
  28. Juan-Mateu, 2015, DMD mutations in 576 Dystrophinopathy families: a step forward in genotype-phenotype correlations, PLoS One, 10, 10.1371/journal.pone.0135189 · DOI
  29. Kameya, 1997, Dp260 disrupted mice revealed prolonged implicit time of the b-wave in ERG and loss of accumulation of beta-dystroglycan in the outer plexiform layer of the retina, Hum. Mol. Genet., 6, 2195, 10.1093/hmg/6.13.2195 · DOI
  30. Koenig, 1987, Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell, 50, 509, 10.1016/0092-8674(87)90504-6 · DOI · Paper page
  31. Kremers, 2018, Measuring retinal function in the mouse, Methods Mol. Biol., 1753, 27, 10.1007/978-1-4939-7720-8_2 · doi:10.1007/978-1-4939-7720-8_2
  32. Kretschmer, 2013, OMR-arena: automated measurement and stimulation system to determine mouse visual thresholds based on optomotor responses, PLoS One, 8, 10.1371/journal.pone.0078058 · DOI
  33. Kretschmer, 2015, A system to measure the optokinetic and Optomotor response in mice, J. Neurosci. Methods, 256, 91, 10.1016/j.jneumeth.2015.08.007 · DOI
  34. Li, 2008, Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein, Am. J. Pathol., 172, 1332, 10.2353/ajpath.2008.071042 · DOI
  35. Miyatake, 2018, Exon skipping therapy using Phosphorodiamidate Morpholino oligomers in the mdx52 mouse model of Duchenne muscular dystrophy, Methods Mol. Biol., 1687, 123, 10.1007/978-1-4939-7374-3_9 · DOI
  36. Mizobe, 2018, In vivo evaluation of single-exon and multiexon skipping in mdx52 mice, Methods Mol. Biol., 1828, 275, 10.1007/978-1-4939-8651-4_17 · doi:10.1007/978-1-4939-8651-4_17
  37. Morris, 1995, Apo-dystrophins (Dp140 and Dp71) and dystrophin splicing isoforms in developing brain, Biochem. Biophys. Res. Commun., 215, 361, 10.1006/bbrc.1995.2474 · DOI
  38. Pardue, 2014, Mouse b-wave mutants, Doc. Ophthalmol., 128, 77, 10.1007/s10633-013-9424-8 · DOI
  39. Pascual Pascual, 1998, Electroretinogram in Duchenne/Becker muscular dystrophy, Pediatr. Neurol., 18, 315, 10.1016/S0887-8994(97)00208-7 · doi:10.1016/s0887-8994(97)00208-7
  40. Perronnet, 2010, Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies, J. Biomed. Biotechnol., 2010, 849426
  41. Pilgram, 2010, The roles of the dystrophin-associated glycoprotein complex at the synapse, Mol. Neurobiol., 41, 1, 10.1007/s12035-009-8089-5 · DOI
  42. Pillers, 1995, mdxCv3 mouse is a model for electroretinography of Duchenne/Becker muscular dystrophy, Invest. Ophthalmol. Vis. Sci., 36, 462
  43. Pillers, 1999, Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations, Hum. Genet., 105, 2, 10.1007/s004399900111 · doi:10.1007/s004399900111
  44. Pillers, 1999, Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of duchenne muscular dystrophy mouse mutants, Mol. Genet. Metab., 66, 100, 10.1006/mgme.1998.2784 · DOI
  45. Regus-Leidig, 2014, Photoreceptor degeneration in two mouse models for congenital stationary night blindness type 2, PLoS One, 9, 10.1371/journal.pone.0086769 · doi:10.1371/journal.pone.0086769
  46. Ricotti, 2016, Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system, Eur. J. Hum. Genet., 24, 562, 10.1038/ejhg.2015.135 · DOI
  47. Ricotti, 2016, Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations, Dev. Med. Child Neurol., 58, 77, 10.1111/dmcn.12922 · DOI · Paper page
  48. Rodius, 1997, Dystrophins in developing retina: Dp260 expression correlates with synaptic maturation, Neuroreport, 8, 2383, 10.1097/00001756-199707070-00056 · DOI
  49. Sigesmund, 1994, Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy, Ophthalmology, 101, 856, 10.1016/S0161-6420(13)31249-4 · DOI
  50. Snow, 2013, Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review, Neurosci. Biobehav. Rev., 37, 743, 10.1016/j.neubiorev.2013.03.016 · DOI · Paper page
  51. Tadayoni, 2012, Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene, Mol. Neurobiol., 45, 43, 10.1007/s12035-011-8218-9 · DOI
  52. Taylor, 2010, Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS One, 5, 10.1371/journal.pone.0008803 · DOI · Paper page
  53. Tremblay, 1994, Duchenne muscular dystrophy: negative scotopic bright-flash electroretinogram but not congenital stationary night blindness, Can. J. Ophthalmol., 29, 274
  54. Tsai, 2016, Asymmetrical functional deficits of ON and OFF retinal processing in the mdx3Cv mouse model of Duchenne muscular dystrophy, Invest. Ophthalmol. Vis. Sci., 57, 5788, 10.1167/iovs.16-19432 · doi:10.1167/iovs.16-19432
  55. Vaillend, 1999, Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins, Neuromuscul. Disord., 9, 296, 10.1016/S0960-8966(99)00029-2 · DOI · Paper page
  56. Wachtmeister, 1978, The oscillatory potentials of the mudpuppy retina, Invest. Ophthalmol. Vis. Sci., 17, 1176
  57. Waite, 2009, The neurobiology of the dystrophin-associated glycoprotein complex, Ann. Med., 41, 344, 10.1080/07853890802668522 · DOI
  58. Wersinger, 2011, Reevaluation of dystrophin localization in the mouse retina, Invest. Ophthalmol. Vis. Sci., 52, 7901, 10.1167/iovs.11-7519 · doi:10.1167/iovs.11-7519

Cited by

See all 11

Metadata

Authors
Barboni, M. T. S., Liber, A. M. P., Joachimsthaler, A., Saoudi, A., Goyenvalle, A., Rendon, A., Roger, J. E., Ventura, D. F., Kremers, J., & Vaillend, C.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2021-05
Volume
152
Pages
105288
ISSN
0969-9961
Cited by
11
References
2
Language
en
Licence
Funders
  • National Research Development and Innovation Office (PD134799)
  • CNPq (404239/2016\u20131, 309,409/2015\u20132)
  • European Cooperation in Science and Technology (CA17103)
  • Deutscher Akademischer Austauschdienst (57513929)
  • National Centre for Scientific Research
  • Université Paris-Sud
  • Hungarian Scientific Research Fund
  • Association Française contre les Myopathies
  • Deutscher Akademischer Austauschdienst France
  • Campus France
  • Tempus Public Foundation
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/26818\u20132, 2016/04538\u20133, 2019/007771)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy. https://app.cochat.ai/papers/10.1016/j.nbd.2021.105288
The paper
Barboni, M. T. S., Liber, A. M. P., Joachimsthaler, A., Saoudi, A., Goyenvalle, A., Rendon, A., Roger, J. E., Ventura, D. F., Kremers, J., & Vaillend, C. (2021). Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2021.105288

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.